Summary Stage 2018: Eye Other

Summary Stage 2018

Notes

**Eye Other** 8000-8700 (C691-C694, C696, C698-C699) 8720-8790 (C691-C692, C695-C696, C698-C699) C691-C696, C698-C699 C691 Cornea, NOS C692 Retina C693 Choroid C694 Ciliary Body C695 Lacrimal Gland C696 Orbit, NOS C698 Overlapping lesion of eye and adnexa C699 Eye, NOS **Note 1:** **Sources used in the development of this chapter** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx **Note 2:** **Other Summary Stage Chapters with other Eye sites** * **GIST**: 8935-8936 * **Kaposi Sarcoma**: 9140 * **Lacrimal Gland and Lacrimal Sac**: C695 (8000-8700, 8941, 8980, 8982) * **Melanoma Uvea**: C693, C694 (8720-8790) * **Mycosis Fungoides**: 9700-9701 * **Orbital Sarcoma** * C691-C694, C696, C698-C699 (8710-8714, 8800-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9138, 9141-9175, 9181-9230, 9240-9509, 9520-9582) * C695 (8710-8714, 8800-8921, 8932-8934, 8940, 8950-8975, 8981, 8983-8990, 9000-9016, 9030-9138, 9141-9175, 9181-9230, 9240-9509, 9520-9582) * **Retinoblastoma**: 9510-9514 * **Soft Tissue**: 8930-8931, 8991-8992, 9020, 9180, 9231 **Note 3:** **Only staging system** * Summary Stage is the only applicable staging system for this site/histology/schema.

NAACCR Item

NAACCR #764
SS2018 Description
0 **In situ: noninvasive, intraepithelial**
1 **Localized only (localized, NOS)** - Confined to tissue or organ of origin - Intraocular extension
2 **Regional by direct extension only** - Adjacent extraocular extension + Eyelid + Orbit
3 **Regional lymph node(s) involved only** - Cervical, NOS + Mandibular, NOS + Submandibular (submaxillary) - Parotid, NOS + Infra-auricular + Preauricular - Regional lymph node(s), NOS + Lymph node(s), NOS
4 **Regional by BOTH direct extension AND regional lymph node(s) involved** - Codes (2) + (3)
7 **Distant site(s)/lymph node(s) involved** - Distant site(s) (including further contiguous extension) - Distant lymph node(s), NOS - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)